ArticleOncology and therapy2025

Cost-Utility Analysis of Multigene Assays to Guide Treatment Decisions for Node-Negative Early Breast Cancer.

Vladislav Berdunov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.